Bladder cancer on cystoscopy most often appears as a papillary growth, a frond-like or finger-like projection rising from the bladder wall into the cavity, sometimes described as resembling a sea anemone or small cauliflower. But that classic image accounts for only one pattern. Tumors can also present as flat red patches, broad-based solid masses, or subtle mucosal changes that even experienced urologists sometimes struggle to distinguish from inflammation. The visual diversity matters because what a tumor looks like through the scope often tracks with how aggressive it is.
The Classic Papillary Tumor
The majority of newly diagnosed bladder cancers are papillary, meaning they grow outward from the bladder lining on slender stalks or branching fronds. Under the white light of a standard cystoscope, these tumors look like soft, waving projections, often pinkish-red but sometimes pale or whitish. They tend to sway in the fluid that fills the bladder during the procedure. Papillary tumors are often small at first detection and are the form most people picture when they think of bladder cancer on cystoscopy. A case report of a rare bladder papilloma described the typical exophytic appearance as a “cauliflower extensive, whitish, and exophytic lesion” rising from the bladder wall, which captures how these growths can look when they are large enough to fill part of the bladder cavity.1PubMed Central. Squamous cell papilloma a rare urinary bladder tumor, case report and operative video
Smaller papillary tumors are typically pedunculated, meaning they sit on a narrow stalk. This shape is a generally reassuring sign. In a prospective study of newly presenting bladder cancers, about 94% of tumors predicted to be low-grade and non-invasive were small (30 mm or less), and the papillary, stalked shape correlated strongly with superficial disease.2Urology. Predicting Grade and Stage at Cystoscopy in Newly Presenting Bladder Cancers—a Prospective Double-Blind Clinical Study That does not mean every papillary tumor is harmless, but the stereotypical frond-on-a-stalk is the form least likely to have invaded deeply into the bladder wall.
Flat Lesions and Carcinoma In Situ
Carcinoma in situ (CIS) is the form of bladder cancer that gives urologists the most trouble during cystoscopy, because it barely looks like a tumor at all. Instead of a raised growth, CIS appears as a flat, velvety red patch on the bladder lining. It can resemble ordinary inflammation, a healing area after a urinary tract infection, or even normal mucosa that happens to be slightly flushed. There is no mass to grab and no stalk to cut, which makes it easy to underestimate.
In one study of patients undergoing cystoscopy for blood in the urine or lower urinary tract symptoms, red patches were biopsied and CIS was found in about 8% of cases, with only half of those patients having a positive urine cytology beforehand.3PubMed Central. Importance of red patches diagnosed in cystoscopy for haematuria and lower urinary tract symptoms That means a urologist relying solely on the visual impression and standard urine tests would miss some cases. CIS is considered high-grade by definition and carries a meaningful risk of progressing to muscle-invasive disease if left untreated, so the stakes of missing it are high.
This is why suspicious flat areas are routinely biopsied even when they look like they could be benign inflammation. The visual appearance alone simply cannot distinguish CIS from a harmless irritated patch.
Sessile and Solid Masses
Not all bladder tumors grow on stalks. Some sit flat against the bladder wall with a broad base, a shape called sessile. Others are frankly solid, bulging into the bladder without the delicate fronds of a papillary tumor. These appearances tend to signal more advanced disease. In that same prospective study, 90% of tumors predicted to be muscle-invasive had a solid or mixed appearance rather than a purely papillary one.2Urology. Predicting Grade and Stage at Cystoscopy in Newly Presenting Bladder Cancers—a Prospective Double-Blind Clinical Study
A meta-analysis of cystoscopic findings in non-muscle-invasive bladder cancer quantified this relationship. Sessile tumors were associated with roughly double the risk of recurrence and progression compared to pedunculated tumors. Solid tumors fared even worse, with about three times the risk of progression compared to papillary ones.4BJU International. Oncological impact of cystoscopic findings in non-muscle-invasive bladder cancer: a meta-analysis On cystoscopy, a solid or sessile mass often appears pale, ulcerated, or necrotic on its surface. It may be surrounded by edematous, swollen-looking mucosa. Blood vessels feeding the mass can sometimes be visible. The overall impression is of something anchored firmly in the wall rather than dangling from it.
What Size, Number, and Location Tell You
Beyond shape, urologists note the tumor’s size, how many tumors are present, and where they sit. Each of these features carries prognostic weight. Tumors 3 cm or larger were associated with roughly double the risk of recurrence and nearly double the risk of progression compared to smaller tumors. Multiple tumors at diagnosis likewise meant worse outcomes, with about a 60% higher recurrence risk.4BJU International. Oncological impact of cystoscopic findings in non-muscle-invasive bladder cancer: a meta-analysis
Location also matters. A large analysis of bladder carcinomas by site found that the lateral walls were the most common location, accounting for about 37% of tumors, followed by the posterior wall at roughly 18% and the trigone (the triangular area near the bladder neck) at about 13%. The trigone had an outsized tendency to harbor squamous cell carcinoma, producing over three times the expected number of squamous tumors compared to other sites.5Cancer. Analysis of bladder carcinoma by subsite. Cystoscopic location may have prognostic value The anterior wall was the least common site at under 4%. This distribution is partly anatomy: urine carrying dissolved carcinogens contacts the lateral and posterior walls more during storage, and the trigone is a zone of transitional tissue prone to metaplasia.
Bladder diverticula, small pouches that bulge outward from the bladder wall, pose a special challenge. Tumors arising inside a diverticulum are harder to see during cystoscopy because the scope has to be maneuvered into the pouch opening. When a tumor is found inside a diverticulum, the lack of a muscular wall layer in most diverticula means cancer there can invade surrounding tissue more easily.6PubMed Central. Bladder carcinoma in a bladder diverticulum: a case report
Things That Look Like Cancer but Are Not
A range of benign conditions can produce bladder masses or mucosal changes that closely mimic cancer on cystoscopy. Inflammatory pseudotumors create ulcerated, bleeding polypoid masses that are visually indistinguishable from malignant tumors.7PubMed. From the archives of the AFIP: Inflammatory and nonneoplastic bladder masses: radiologic-pathologic correlation Malakoplakia, a rare chronic inflammatory condition, can produce soft yellow plaques, nodules, or sessile masses scattered across the bladder, closely resembling a multifocal bladder cancer.8PubMed Central. Recurrent bladder malakoplakia: A rare bladder lesion mimicking malignancy In one case, flexible cystoscopy revealed multiple diffuse sessile masses throughout the bladder that turned out to be malakoplakia on biopsy.9PubMed Central. Bladder malakoplakia mimicking a bladder tumor: A case report and brief review of the literature
Other benign mimics include cystitis cystica and cystitis glandularis, conditions where the bladder lining forms small cysts or glandular structures that can create bumpy, raised areas on the wall. Radiation cystitis in patients who have had pelvic radiation therapy can cause diffuse mucosal changes, neovascularization, and bleeding that raises concern for recurrent cancer. The critical takeaway is that a biopsy is the only way to confirm what a suspicious lesion actually is. Visual assessment during cystoscopy narrows the possibilities but never replaces tissue diagnosis.
Post-Treatment Appearances That Complicate Surveillance
Patients who have been treated for bladder cancer return for regular surveillance cystoscopies, and the treated bladder often looks different from a normal one. After BCG immunotherapy, which is the most common intravesical treatment for non-muscle-invasive bladder cancer, the bladder lining frequently develops granulomatous inflammation, scarring, and erythematous patches. These BCG-induced changes can look alarmingly similar to recurrent cancer on cystoscopy.
A study examining the long-term course of BCG-induced bladder lesions found that benign post-treatment lesions cannot be reliably distinguished from cancer recurrence by cystoscopy alone, even with narrow band imaging. However, most of these BCG-related lesions have a good prognosis and tend to resolve over time, which means that in patients with long-term negative biopsies and negative urine cytology, additional biopsies of these changes can sometimes be deferred.10PubMed Central. The natural course of bacillus Calmette-Guérin induced bladder lesions: A long-term follow-up study and systematic review For patients undergoing surveillance, understanding that post-treatment inflammation is expected can help reduce anxiety when the urologist notes redness or thickening at follow-up.
Prior transurethral resection sites also leave visible scars. Fresh resection beds look white or pale with surrounding hyperemia for weeks after surgery. Over months, a smooth scar typically forms. If a papillary or solid growth appears at a previous resection site, that raises immediate suspicion for recurrence.
Enhanced Imaging Technologies
Standard cystoscopy uses white light, which has obvious limitations for detecting flat lesions. Two enhanced imaging methods have changed what urologists can see.
Blue Light Cystoscopy
Blue light cystoscopy (also called photodynamic diagnosis or fluorescence cystoscopy) uses a photosensitizing agent, typically hexaminolevulinate, instilled into the bladder before the procedure. Cancer cells preferentially absorb this agent and fluoresce pink or red under blue-violet light, making them stand out against the normal blue-appearing mucosa. A large U.S. prospective registry found that standard white light cystoscopy detected malignant lesions with 76% sensitivity, while blue light raised that to 91%. Combining the two approaches pushed sensitivity to about 99%. Blue light improved detection of papillary lesions by 12% and CIS detection by 43%, and in patients where white light found nothing, blue light identified additional lesions in a quarter of them.11Urologic Oncology: Seminars and Original Investigations. Blue light cystoscopy for the diagnosis of bladder cancer: Results from the US prospective multicenter registry
A meta-analysis comparing photodynamic diagnosis with white light cystoscopy similarly found higher sensitivity for PDD (about 92% versus 71%), with the advantage being especially pronounced for higher-risk tumors, where PDD sensitivity was about 89% versus 56% for white light.12International Journal of Technology Assessment in Health Care. Photodynamic diagnosis of bladder cancer compared with white light cystoscopy: Systematic review and meta-analysis The trade-off is lower specificity: inflammation, recent instrumentation, and BCG treatment can all cause false-positive fluorescence.13PubMed Central. Optimizing Diagnosis of Urothelial Bladder Cancer with Blue Light Cystoscopy via Recognition of False-Positive Lesions
Narrow Band Imaging
Narrow band imaging (NBI) filters the cystoscope’s light to just two narrow wavelengths that are strongly absorbed by hemoglobin, making blood vessels on the bladder surface appear dark and highly detailed against a lighter background. Because bladder tumors typically recruit their own blood supply, they show up as areas of dense, irregular vasculature under NBI, even when they look unremarkable under white light. Research has shown improved sensitivity for NBI over conventional white light, though as with blue light, specificity is somewhat lower, meaning more benign areas get flagged as suspicious.14PubMed Central. Narrow band imaging for bladder cancer The advantage of NBI over blue light is that it requires no drug instillation, so it can be used during routine surveillance without extra preparation time. Both technologies are increasingly available but not yet universal in every urology practice.
The Role of Biopsy During Cystoscopy
Cystoscopy is a visual procedure, but the definitive answer always comes from tissue. When a urologist sees something suspicious, they can take a biopsy during the same session, either using cold-cup forceps to pinch a sample or a resection loop to cut through the tumor. The choice affects what the pathologist receives. A study comparing cold-cup biopsy to resection biopsy found that both had similar accuracy for diagnosing muscle invasion, but the cold-cup technique retrieved adequate detrusor muscle (the deep layer the pathologist needs to see) more often, about 87% of the time versus 65% with loop resection.15PubMed Central. Comparison of Cold-Cup Biopsy Versus Resection Biopsy in the Early Detection of Detrusor Muscle Invasion in the Case of Bladder Tumor Better tissue sampling reduces the chance of needing a second procedure to determine how deeply the cancer has invaded.
Urine cytology and biomarker tests complement what is seen during cystoscopy. Cytology, examining shed cells in the urine under a microscope, is highly specific for high-grade cancer but misses many low-grade tumors. When cytology returns an indeterminate or “suspicious” result, ancillary urine biomarker tests can help clarify whether cancer is present.16PubMed. Urine cytology suspicious for urothelial carcinoma: Prospective follow-up of cases using cytology and urine biomarker-based ancillary techniques These tests are not replacements for cystoscopy but add a layer of information, particularly useful when visual findings are equivocal.
Flexible Versus Rigid Cystoscopy
Most initial diagnostic and surveillance cystoscopies are done with a flexible cystoscope, a thin, bendable instrument inserted through the urethra. The image quality has improved dramatically over the past two decades and is now sufficient for detecting most lesions. A rigid cystoscope offers a wider field of view and allows resection of tumors during the procedure, but typically requires sedation or anesthesia. In women, a study comparing the two approaches found no statistically significant difference in patient-reported discomfort, with median pain scores of 1.4 and 1.8 on a 10-point scale for flexible and rigid respectively.17PubMed Central. Flexible and rigid cystoscopy in women In men, the difference is generally more pronounced because the rigid scope traverses a longer, more curved urethra, which is why flexible cystoscopy is the default for office-based evaluations in male patients.
From a visual standpoint, the same types of lesions are visible with either instrument. The practical difference is that a flexible scope is used to look and possibly biopsy small areas, while a rigid scope is brought out when the plan already includes resecting a tumor, an operation called transurethral resection of bladder tumor (TURBT).
Artificial Intelligence in Cystoscopic Interpretation
A growing body of work is exploring whether AI systems can help urologists interpret what they see during cystoscopy in real time. A multicenter study developed an AI diagnostic system trained on cystoscopy images that could identify bladder cancer and distinguish it from normal or benign findings.18PubMed Central. An Artificial Intelligence System for the Detection of Bladder Cancer via Cystoscopy: A Multicenter Diagnostic Study A more recent system combining AI with narrow band imaging achieved about 92% accuracy for identifying bladder cancer and about 76% accuracy for predicting tumor grade, meaning it could flag not just whether something is cancer but whether it is likely low-grade or high-grade.19iScience. Artificial intelligence diagnostics for bladder tumor identification and grade prediction depend on narrow band imaging cystoscopy Another approach using deep learning on standard RGB cystoscopy images showed the ability to outline tumor boundaries and color-code them by predicted grade.20Scientific Reports. Deep learning diagnostics for bladder tumor identification and grade prediction using RGB method
These tools are not yet standard clinical equipment. Their promise lies in reducing the variability between individual urologists (some are better at spotting subtle lesions than others) and potentially catching flat or small lesions that a human eye, tired after a long day in the procedure suite, might overlook. The false-positive rate remains a concern, particularly in post-treatment bladders where inflammation is common, so these systems will likely function as a second set of eyes rather than as autonomous diagnosticians.